Regeneron's Otarmeni gains EMA review for genetic hearing loss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. SPY
6. ACN
7. NVDA
8. IBM
9. PFE
10. TSLA

Go back to Regeneron's Otarmeni gains EMA review for genetic hearing loss
Regeneron (NASDAQ: REGN) Delayed: 618.40 +5.90 (0.96%)
Previous Close $612.50    52 Week High $592.36 
Open $607.92    52 Week Low $325.35 
Day High $621.79    P/E 162.31 
Day Low $607.92    EPS $3.81 
Volume 365,219